The Supply of Doxycycline & Placebo for the AFLOAT Trial
key details
| Value | £64,590 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | South East |
| Deadline | 7 Feb 2024 |
| Contract start | 7 Apr 2024 |
| Contract end | 31 Dec 2027 |
| Procedure | limited |
| SME suitable | No |
| OCID | ocds-b5fd17-065382d5-f96c-4a89-8b88-b38494143052 |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| Modepharma Limited | £64,590 | 6 Mar 2024 | active |
description
AFLOAT Study - Antibiotics for acute LRTI in Older People
AFLOAT is a publicly-funded (NIHR) and academic-sponsored (University of Southampton) Clinical Trial of an Investigational Medicinal Product (CTIMP).
Aim: The aim is to assess whether time until all symptoms are rated absent or mild is no worse in those who take placebo vs antibiotics in adults aged 65 and over who are seen in primary care with LRTI and risk factors for complications.
Patients with LRTI will be recruited from primary care sites and randomised to receive either Doxycycline (100mg twice a day on the first day and then 100 mg once a day
for 4 days) or matching placebo. The drugs will be identical in taste and appearance and stored in sealed blind-sequence medication containers holding a 5-day supply of either doxycycline or placebo.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 15 Apr 2024 | Award (award) | · | c90bd42f-d631-4b95-9443-9608ade53a4d-732027 |
more from UNIVERSITY OF SOUTHAMPTON
- English Language Print Books for Library Stock · £1,000,000 · 23 Mar 2026
- Qlik Licences · £390,612 · 20 Mar 2026
- Provision of Cognos Licences · £82,699 · 24 Feb 2026
- Valley Graphics Van Lease · £16,636 · 20 Feb 2026
- Provision of Apple Products · £2,000,000 · 2 Feb 2026
- Provision of Valley Graphics Print Machines · £259,820 · 22 Jan 2026
- VMware Server Storage · £275,175 · 9 Jan 2026
- Provision of Hexagon Actran Licences · £50,685 · 23 Dec 2025
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.